On Friday, May 11th the Trump Administration unveiled its plan to lower prescription drug prices. The proposal allows for more negotiation for Medicare drug prices through Part D drug plans. Additionally, the plan hopes to create more competition in the drug industry, expedite the availability of generic drugs, and reduce the amount paid to middlemen. No timeline for the implementation of the plan has been provided. For more information please see The Washington Post.